Home | Welcome to Contract Pharma   
Last Updated Monday, May 25 2015


Financial Report: WuXi Pharma Tech 3Q

Published November 13, 2012
WuXi Pharma Tech

3Q Revenues: $125.8 million (+21%)

3Q Earnings: $213 million (+3%)

YTD Revenues: $374.3 million (+25%)

YTD Earnings: $62.8 million (+9%)

Comments: Laboratory Services were $98.9 million in the quarter, up 26%. China-based Lab Services increased 32% to $77.0 million. U.S.-based Lab Services were up 6% to $21.9 million. Manufacturing services were $26.9 million, up 7%.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On